Prudential PLC Supernus Pharmaceuticals, Inc. Transaction History

Prudential PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$26.72 - $33.19 $6.47 Million - $8.04 Million	-242,100 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$24.15 - $31.45 $5.85 Million - $7.61 Million	242,100 New	242,100 $6.34 Million
Q4 2019 Feb 13, 2020	SELL	$19.93 - $29.13 $1.81 Million - $2.65 Million	-90,855 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$29.96 - $38.87 $2.72 Million - $3.53 Million	90,855 New	90,855 $3 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.98B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

Stay updated on Prudential PLC with notifications on news.